City of Hope Feb 22, 2022 CAR T-Cell Therapies Show Early Promise Against Advanced Prostate Cancer Premium Feb 22, 2022 Expert Reviews of NGS Reports Helping Community Docs Clear 'Last Mile' Hurdle in Precision Oncology Premium Dec 15, 2021 Amgen Turning to Combination Strategies After Limited Lumakras Efficacy in KRAS-Mutated Colon Cancer Nov 19, 2021 City of Hope Begins Oncolytic Virus Trial in Triple-Negative Breast Cancer Oct 8, 2021 TGen Study Highlights Value of Repeat Tumor Profiling for Pediatric Solid Tumors Premium Jul 13, 2021 Cyclacel Pharmaceuticals Doses First Patient in CDK2/9 Inhibitor Basket Trial Jul 2, 2021 In Brief This Week: Syndax, Transgene, Sermonix, AccessHope, Achilles, Foundation Medicine May 20, 2021 Imugene Licenses Oncolytic Virus From City of Hope to Boost CAR T-Cell Efficacy in Solid Tumors May 20, 2021 Mustang Bio Initiates CAR T-Cell Therapy in Phase I Brain Tumor Trial Apr 2, 2021 City of Hope Supporting Precision Oncology Education Efforts at Brazilian Hospital Apr 2, 2021 In Brief This Week: Merck, Taiho Oncology, Guardant Health, City of Hope, Bluestar Genomics Dec 22, 2020 Mustang Bio, City of Hope Initiate Clinical Trial of CAR T-cell Therapy in Brain Cancer Patients Oct 5, 2020 Blood-Based Gene Expression Signature May ID Prostate Cancer Patients' Response to Hormonal Drugs Apr 17, 2020 Interactive Tool to Improve Patients' Understanding of Genetic Test Reports Gets Positive Reception Feb 1, 2019 Precision Medicine Platform for Oncology Aims to Streamline Molecular Testing, Therapy Decision-Making Premium Breaking News FDA Approves Taiho Oncology's Lytgobi for FGFR2-Rearranged Bile Duct Cancer Gladstone Institute Joins With Parker Institute on New Center to Study CRISPR-Based Cell Therapies Meliora Therapeutics Raises $11M in Seed Financing In Brief This Week:Â Verismo Therapeutics, Fore Biotherapeutics, Merck, Caris Life Sciences Tumor-Only Sequencing Found to Overestimate Mutational Burden in Non-European Patients Atara Biotherapeutics to Net $30M From Pierre Fabre for European Tab-Cel Approval
